Using state administrative and pharmacy data bases to develop a clinical decision support tool for schizophrenia guidelines

Schizophrenia Bulletin

Volumn 28, Issue 1, 2002, Pages 85-94

  Finnerty, Molly ^a   Altmansberger, Richard ^a   Bopp, James ^a   Carpinello, Sharon ^a   Docherty, John P ^a   Fisher, William ^a   Jensen, Peter ^a   Krishnan, Parukutty ^a   Mittleman, Michael ^a   Olfson, Mark ^a   Tricarico, Joel ^a   White, Tom ^a   Felton, Chip ^a  

^a CPEOM   (United States)

Author keywords

Antipsychotic agents; Clinical decision support; Evidence based medicine; Guideline adherence; Guideline implementation; Quality indicators; Schizophrenia

Indexed keywords

CHLORPROMAZINE; CLONAZEPAM; CLOZAPINE; DECANOIC ACID; FLUPHENAZINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; LORAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROATE SEMISODIUM; ZIPRASIDONE;

ADULT; ALGORITHM; ARTICLE; CONTROLLED STUDY; DATA BASE; DECISION MAKING; EVIDENCE BASED MEDICINE; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PHARMACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCHIZOPHRENIA; DECISION SUPPORT SYSTEM; DRUG INFORMATION; HEALTH CARE QUALITY; LENGTH OF STAY; OUTCOME ASSESSMENT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; TREATMENT OUTCOME; UNITED STATES;

ANTIPSYCHOTIC AGENTS; DATABASES; DECISION SUPPORT SYSTEMS, CLINICAL; DRUG INFORMATION SERVICES; EVIDENCE-BASED MEDICINE; HUMANS; LENGTH OF STAY; NEW YORK; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES; PSYCHIATRIC STATUS RATING SCALES; QUALITY ASSURANCE, HEALTH CARE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 0035988526     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a006929     Document Type: Article

References (27)

1. Practice patterns and hospitalization rates
2. Using a computer data base to monitor compliance with pharmacotherapeutic guidelines for schizophrenia
3. Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998
4. The treatment of depression: Prescribing patterns of antidepressants in primary care in the U.K.
5. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia
6. Evaluation of the HEDIS measure of behavioral health care quality
7. Guideline recommendations for pharmacological management of schizophrenia
8. Process measures for the assessment and improvement of quality of care for schizophrenia
9. Quality measures for mental health care: Results of a national survey
10. The feasibility of using automated data to assess guideline-concordant care for schizophrenia
11. Lithium use and discontinuation in a health maintenance organization
12. Adequacy and duration of antidepressant treatment in primary care
13. Collaborative management to achieve treatment guidelines: Impact on depression in primary care
14. Use of pharmacy data to assess quality of pharmacotherapy for schizophrenia in a national health care system: Individual and facility predictors
15. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression
16. Helping clinicians to find data and avoid delays
17. Depression, health related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment
18. Medication treatment for the severely and persistently mentally ill: The Texas Medication Algorithm Project
19. Assessing the feasibility of using computerized pharmacy refill data to monitor antidepressant treatment on a population basis: A comparison of automated and self-report data
20. Patterns of antidepressant use in a community practice
21. Care for depression in HMO patients aged 65 and older
22. The use of administrative data to assess quality of care for bipolar disorder in a large staff model HMO
23. Impact of disseminating quality improvement programs for depression in managed primary care: A randomized controlled trial